Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|32|4975-4980

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.32, 2016-09, pp. : 4975-4980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments

By Eerdenbrugh Bernard   Raina Shweta   Hsieh Yi-Ling   Augustijns Patrick   Taylor Lynne  

Pharmaceutical Research, Vol. 31, Iss. 4, 2014-04 ,pp. : 969-982

Springer Publishing Company

Access to resources Recommend Favorite

Amorphous Active Pharmaceutical Ingredients in Preclinical Studies: Preparation, Characterization, and Formulation

By  

Current Bioactive Compounds, Vol. 4, Iss. 4, 2008-12 ,pp. : 213-224

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphism and Crystallization of Active Pharmaceutical Ingredients (APIs)

By  

Current Medicinal Chemistry, Vol. 16, Iss. 7, 2009-03 ,pp. : 884-905

Bentham Science Publishers

Access to resources Recommend Favorite

Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients

By  

Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. : 2456-2472

Bentham Science Publishers

Access to resources Recommend Favorite

Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients

By  

Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. : 2339-2348

Bentham Science Publishers

Access to resources Recommend Favorite